Pfizer: Keep On Reinvesting Dividends

Summary

Donald Trump calls out the company on its price hikes.

Shares not adversely affected.

The dividend still looks strong.

This idea was discussed in more depth with members of my private investing community, Elevation Code.

We are long Pfizer (PFE) since around the $34 level. Whilst this long play has been a slow burner for us, the range-bound nature of shares has meant that one can compound their money faster due to being able to reinvest dividends at higher yields. As the chart shows below, shares have been pretty range-bound for the best part of 8 months now but have been trending higher over a longer time frame. The next resistance would be the January highs of just over $39. Shares are trading well above the 200-day moving average of $35.72 which is encouraging as sentiment is dead neutral in the stock at present.

Source : Sentimentrader.com

READ FULL ARTICLE HERE